Hofmeister Robert 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-09+100,000→ 100,000 totalExercise: $5.21Exp: 2031-12-08→ Common Stock (100,000 underlying)
Holdings
- 45,850
Common Stock
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.